Are CML patients being treated to the correct standard?
Are CML patients being treated to the correct standard?
EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM
Overview of innovation in Hodgkin's lymphoma
Applications of chimaeric antigen receptor T-cells in leukaemia
Minimal residual disease in multiple myeloma
Immunoconjugates address unmet needs in Hodgkin's lymphoma patients
EHA 2015: Expert opinions on new treatment standard in multiple myeloma
Exploring "bad luck" - why do some patients develop myeloid leukaemia?
Genomic sequencing to find AML-causing mutations
The latest in multiple myeloma: a European and US perspective
Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia
Advances in the treatment and management of CLL